0001707315-22-000007.txt : 20221017 0001707315-22-000007.hdr.sgml : 20221017 20221017124121 ACCESSION NUMBER: 0001707315-22-000007 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221017 DATE AS OF CHANGE: 20221017 EFFECTIVENESS DATE: 20221017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Thunder Biotech, Inc. CENTRAL INDEX KEY: 0001707315 IRS NUMBER: 813738317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-461723 FILM NUMBER: 221313180 BUSINESS ADDRESS: STREET 1: 180 NORTH UNIVERSITY AVENUE STREET 2: SUITE 820 CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-367-9298 MAIL ADDRESS: STREET 1: 180 NORTH UNIVERSITY AVENUE STREET 2: SUITE 820 CITY: PROVO STATE: UT ZIP: 84601 D/A 1 primary_doc.xml X0708 D/A LIVE 0001707315 Thunder Biotech, Inc. 180 NORTH UNIVERSITY AVENUE SUITE 820 PROVO UT UTAH 84601 801-367-9298 DELAWARE None None Corporation true Kent A. Misener 180 North University Avenue Suite 820 Provo UT UTAH 84601 Director Robert P.K. Mooney 180 North University Avenue Suite 820 Provo UT UTAH 84601 Executive Officer Director Kim L. O'Neill 180 North University Avenue Suite 820 Provo UT UTAH 84601 Executive Officer Director Morris Linton 180 North University Avenue Suite 820 Provo UT UTAH 84601 Executive Officer Steven A. Tanner 180 North University Avenue Suite 820 Provo UT UTAH 84601 Director James Burgess 180 North University Avenue Suite 820 Provo UT UTAH 84601 Executive Officer Barry D. Mower 180 North University Avenue Suite 820 Provo UT UTAH 84601 Director Jeffrey R. Nelson 180 North University Avenue Suite 820 Provo UT UTAH 84601 Director J. Anthony Antonelli 180 North University Avenue Suite 820 Provo UT UTAH 84601 Director Biotechnology Decline to Disclose 06b true 0001707315-22-000005 2022-09-16 false true false 250000 Mann Mann Jensen Partners LP 137389 None None 1270 Avenue of the Americas 7th Floor New York NY NEW YORK 10020 UT UTAH false 20000000 1000000 19000000 false 1 800000 true 0 true 4% commission on covered sales; up to $1,000 expense reimbursement 1530000 true false Thunder Biotech, Inc. /s/ James Burgess James Burgess VP Finance (CFO) 2022-10-17